ALLMedicine™ Anal Cancer Center

Mar 4th, 2021 - Anal cancer screening has been recommended for women with lower genital tract neoplasia, lupus, Crohn disease, HIV, and/or organ transplantation recipients. This study described and compared knowledge, attitudes, and experiences related to anal ca...

Mar 1st, 2021 - Squamous cell carcinoma is the most common variant of anal malignancy. Certain disease-related factors have been established in determining survival. These include tumour size, differentiation and nodal involvement. Other factors such as HIV statu...

Feb 19th, 2021 - Anal cancer is rare in the general population but is steadily increasing in incidence over the past decade especially in women. Identification and screening of women with high risk facilitates detection of anal precancer and early-stage cancer, im...

Feb 17th, 2021 - Women living with HIV (WLWH) are at increased risk of anal cancer compared to women without HIV, often due to persistent human papillomavirus (HPV) infections. This paper describes current practices and challenges conducting anal cancer screening ...

Feb 13th, 2021 - Anal cancer has increasing incidence and is preceded by high-grade anal intraepithelial neoplasia (HGAIN; AIN2-3). Previously, we identified and validated several methylation markers for accurate detection of anal cancer and HGAIN with cancer risk...

Jan 13th, 2021 - Incidence and Mortality Estimated new cases and deaths from anal, anal canal, and anorectal cancer in the United States in 2021:[1]

Jan 16th, 2019 - Background: Chemotherapy with or without pelvic radiotherapy (RT) is included in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for metastatic anal cancer (MAC), despite limited clinical evidence for RT in this setting. In add...

Aug 13th, 2018 - People living with HIV (PLWH) are diagnosed with cancer at an increased rate over the general population and generally have a higher mortality due to delayed diagnoses, advanced cancer stage, comorbidities, immunosuppression, and cancer treatment ...

Jul 14th, 2018 - The NCCN Guidelines for Anal Carcinoma provide recommendations for the management of patients with squamous cell carcinoma of the anal canal or perianal region. Primary treatment of anal cancer usually includes chemoradiation, although certain les...

Jun 30th, 2018 - Squamous cell cancers of the anal canal and perianal region remain one of the least common malignancies arising from the alimentary tract. As of 2016, it is estimated that 8200 new cases of squamous cell cancers of the anus were diagnosed in the U.

Mar 4th, 2021 - Anal cancer screening has been recommended for women with lower genital tract neoplasia, lupus, Crohn disease, HIV, and/or organ transplantation recipients. This study described and compared knowledge, attitudes, and experiences related to anal ca...

Mar 1st, 2021 - Squamous cell carcinoma is the most common variant of anal malignancy. Certain disease-related factors have been established in determining survival. These include tumour size, differentiation and nodal involvement. Other factors such as HIV statu...

Feb 21st, 2021 - HIV-positive patients who are adherent with antiretroviral medications are achieving undetectable or very low levels of HIV viremia and living longer. In response, clinical care is continually adapting to the dramatically altered natural history o...

Feb 19th, 2021 - Anal cancer is rare in the general population but is steadily increasing in incidence over the past decade especially in women. Identification and screening of women with high risk facilitates detection of anal precancer and early-stage cancer, im...

Feb 17th, 2021 - Women living with HIV (WLWH) are at increased risk of anal cancer compared to women without HIV, often due to persistent human papillomavirus (HPV) infections. This paper describes current practices and challenges conducting anal cancer screening ...

Feb 21st, 2021 - HIV-positive patients who are adherent with antiretroviral medications are achieving undetectable or very low levels of HIV viremia and living longer. In response, clinical care is continually adapting to the dramatically altered natural history o...

Jan 13th, 2021 - Incidence and Mortality Estimated new cases and deaths from anal, anal canal, and anorectal cancer in the United States in 2021:[1]

Nov 4th, 2020 - Radiotherapy plays an important role in the treatment of anal cancer, but many female survivors treated with pelvic radiotherapy develop long-term sexual problems. A new study shows that it is possible to reduce the dose of radiation reaching the ...

Jun 24th, 2020 - UPDATED with comments  June 25, 2020 // This story has been updated with comments about the study from Dr Michael Buckstein. Carboplatin plus paclitaxel should now be considered the standard of care for patients with advanced anal cancer, in place...

Jun 23rd, 2020 - NEW YORK (Reuters Health) - In patients with advanced anal cancer, carboplatin plus paclitaxel was associated with less toxicity and a trend toward longer survival compared with cisplatin and fluorouracil (FU), in a midstage study. These results "...